William Fawcett
Acute Care · Philadelphia, PANPI 1376794925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,138 and has fallen 82.2% since, to $202 in 2024. Among acute care clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$403
- Amgen$383
- Amarin Pharma, Inc.$326
- Novartis$302
- Impulse Dynamics (USA) Inc.$181
- Boehringer Ingelheim$172
- plus $947 from 12 others
What the payments were for
- Food & beverage$2,714100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 21 | $403 |
| Amgen | 18 | $383 |
| Amarin Pharma, Inc. | 21 | $326 |
| Novartis | 19 | $302 |
| Impulse Dynamics (USA) Inc. | 6 | $181 |
| Boehringer Ingelheim | 11 | $172 |
| Sanofi-aventis U.S. LLC | 7 | $169 |
| Astellas Pharma US Inc | 6 | $169 |
| AstraZeneca | 8 | $131 |
| Kowa Pharmaceuticals America, Inc. | 12 | $119 |
| Bayer | 5 | $98 |
| Edwards Lifesciences | 4 | $73 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $40 |
| Scpharmaceuticals Inc. | 2 | $32 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $29 |
| Corcept Therapeutics | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$2,714 in reported general payments places this provider in the 90th percentile of 872 acute care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Other acute care in Philadelphia
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- David JonesPhiladelphia$11K
- Colleen KollerPhiladelphia$11K
- Maura LevandowskiPhiladelphia$9K
- Christopher SipalaPhiladelphia$9K
- Amaryah YaegerPhiladelphia$7K
- Shane RudolphPhiladelphia$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.